Often failing to fulfill its assigned mandates and unable to implement the initiatives it has begun, the UN's World Health Organization desperately needs to reform.

A recent case reveals that it is not only generic firms from middle income countries that have problems with good manufacturing practice.

China, a major link in the world's pharmaceutical supply chain, is taking steps and forming international partnerships to improve drug safety and combat drug counterfeiting.

The Food and Drug Administration has very real shortcomings. But is new regulation the best solution?

The World Health Organization's anti-counterfeit drug task force should broaden its scope to fight the scourge of substandard pharmaceuticals.

Microfinance institutions do not offer a panacea for poverty, but they can play a significant role in development.

Many deaths that occur from malaria each year could be avoided if antimalarial drugs were effective, of good quality, and used correctly.

Aid agencies, advocates, and national governments have a responsibility to ensurethatbillions of dollars inpharmaceutical procurementare spent on safe, effective, life-saving drugs.